Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...

The contingent value right (CVR) offered by BMS as a sweetener for the $74 billion takeover of Celgene in 2019 is defunct, as one of the three drugs – CAR-T therapy liso-cel for lymphoma ...

Our new leadership team continues to author a new future for Pineapple Energy, with a focus on elevating our corporate governance, properly aligning our cost structure, creating a new corporate ...

Pineapple Energy (PEGY) will distribute to the holders of its non-transferable Contingent Value Rights a payment of $850,269, or $0.35 per CVR.

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

Tang’s recent bid was to buy up the remainder of Kezar’s shares for $1.10 apiece, along with a contingent value right for ... said it had introduced a “rights plan” that would incur ...

Total revenue for the fiscal third quarter of 2024 was $95.4 million, and consisted of $68.1 million in Digital asset ...

Offer likely contingent on FDA approval of NDA filed ... as a combination of upfront cash and sales related contingent value rights. - Based on $2 billion in peak sales for treating HSDD, fair ...

Welcome to the Contingent Election, another quirky land mine in our sacred Constitution, a charming document that takes for granted in its charming naivete that we all will not go insane at ...

“We intend the Rights Plan to enable all of our stockholders to realize the long-term value of their investment. The Rights Plan should reduce the likelihood that any person or group gains ...

AUSTIN, Texas–(BUSINESS WIRE)–$CORZ #aicloud—Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for bitcoin mining and HPC, today ...